What does the data and overall understanding of VEGF-TKIs tell us about which patients are optimal candidates for tivozanib? Treatment for advanced renal cell carcinoma (aRCC) commonly includes immune-oncology therapies and tyrosine kinase ... The U.S. Food and Drug Administration approved pembrolizumab (Keytruda®) in combination with axitinib (Inlyta®) for ...